AzTrials
AzTrials

StrokeNCT03502122

Design and Verification of Individualized Smart Assistive Devices for Stroke Rehabilitation

A study testing VR rehabilitation for motor function in people with Stroke, run by National Central University, Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to design and verify a multi-mode smart assistive device system for Stroke Rehabilitation by using EEG, fMRI, IMU and questioners Read more about this study

Who is it for?
Ages 20 to 85 years
Conditions the study is for
Stroke
What is being tested?
VR rehabilitation for motor function
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
No sites listed yet
Study dates
24 Apr 2012to 28 May 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • the first time hemiparetic stroke;
  • diagnosis confirmed by a physician on the basis of the findings of neurological examinations and brain imaging (magnetic resonance imaging or computed tomography scan);
  • aged between 20 and 85 years;
  • Brunnstrom's stage II to V over the proximal and distal part of the upper extremity on the affected side;
  • no cognitive dysfunction, measured by the Mini-Mental State Exam (≧24; suggested by 36 with respect to age and educational level)
  • willing/able to participate and having signed an informed consent form.

Who cannot join

  • unstable vital sign
  • irreversible contracture over any of the joints of the affected upper extremity
  • history of surgery, fracture, arthritis, pain, or any other complications that might influence the recovery of upper extremity function like aphasia, apraxia and neglect;
  • having spasticity, as measured using the Modified Ashworth scale (score > 2);
  • poststroke seizure;
  • heart attack within 3 months poststroke; cortical lesions in any of the five core motor areas of interest, including the bilateral M1, the bilateral PM, and the SMA.

About this study

This study aims to design and verify a multi-mode smart assistive device system for Stroke Rehabilitation by using EEG, fMRI, IMU and questioners

Conditions
Stroke
Being tested
VR rehabilitation for motor function
Keywords
stroke, rehabilitation
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VR rehabilitation for motor functionOther

    Also called VR rehabilitation therapy

    rehabilitation for motor function

Study groups in NCT03502122
Study groupRoleWhat they receive
VR rehabilitationExperimentalVirtual Reality based rehabilitation therapy for motor function, 1 hour a time at an intensity of three times per week over 8 weeks (total, 24 sessions).
Receives: Other: VR rehabilitation for motor function
control- conventional rehabilitationActive comparatorconventional rehabilitation therapy for motor function, 1 hour a time at an intensity of three times per week over 8 weeks (total, 24 sessions).
Receives: Other: VR rehabilitation for motor function

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in FUGL- MEYER ASSESSMENT OF PHYSICAL PERFORMANCE (FMA)

    FUGL- MEYER ASSESSMENT OF PHYSICAL PERFORMANCE (FMA)

    Measured: pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )

Secondary outcomes (3)
  1. change in upper extremity performance evaluation test for the elderly (TEMPA)

    upper extremity performance evaluation test for the elderly (TEMPA)

    Measured: pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )

  2. change in Brunnstrom stage

    Brunnstrom stage

    Measured: pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )

  3. change in Wolf motor function

    Wolf motor function

    Measured: pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2018
  2. Study start24 Apr 2012
  3. Primary completion28 May 2014
  4. Study completion28 May 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
48 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03502122
Sponsor's protocol ID
201012009IA
Status last verified
Jul 2018
First submitted
31 Mar 2018
Last updated
5 Jul 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: undecided .

Questions about this trial

What is this clinical trial studying?

A study testing VR rehabilitation for motor function in people with Stroke, run by National Central University, Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in FUGL- MEYER ASSESSMENT OF PHYSICAL PERFORMANCE (FMA) (time frame: pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in